(Q44277885)

1 December 2017

Lipophilicity of analogs of pyridoxal isonicotinoyl hydrazone (PIH) determines the efflux of iron complexes and toxicity in K562 cells (English)

1 reference

1 December 2017

Joan L Buss

1

1 reference

1 December 2017

Emmanuele Arduini

series ordinal

2

1 reference

1 December 2017

Kyle C Shephard

series ordinal

3

1 reference

1 December 2017

Prem Ponka

series ordinal

4

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

1 December 2017

Biochemical Pharmacology

1 reference

1 December 2017

65

1 reference

1 December 2017

3

1 reference

1 December 2017

349-360

1 reference

Oxygen toxicity, oxygen radicals, transition metals and disease

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901551-4

The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901551-4

Studies in Desferrioxamine and Ferrioxamine Metabolism in Normal and Iron-Loaded Subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901551-4

A study of intracellular iron metabolism using pyridoxal isonicotinoyl hydrazone and other synthetic chelating agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901551-4

Biliary iron excretion in rats following pyridoxal isonicotinoyl hydrazone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901551-4

Evaluation of the iron chelation potential of hydrazones of pyridoxal, salicylaldehyde and 2-hydroxy-1-naphthylaldehyde using the hepatocyte in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901551-4

Effect of pyridoxal isonicotinoyl hydrazone and other hydrazones on iron release from macrophages, reticulocytes and hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901551-4

Mobilization of intracellular iron by analogs of pyridoxal isonicotinoyl hydrazone (PIH) is determined by the membrane permeability of the iron-chelator complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901551-4

In vitro effects of three iron chelators on mitogen-activated lymphocytes: identification of differences in their mechanisms of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901551-4

Development of novel aroylhydrazone ligands for iron chelation therapy: 2-pyridylcarboxaldehyde isonicotinoyl hydrazone analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901551-4

A study of the mechanism of action of pyridoxal isonicotinoyl hydrazone at the cellular level using reticulocytes loaded with non-heme 59Fe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901551-4

Iron transport in K562 cells: a kinetic study using native gel electrophoresis and 59Fe autoradiography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901551-4

Ferric pyridoxal isonicotinoyl hydrazone can provide iron for heme synthesis in reticulocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901551-4

Evidence that transferrin supports cell proliferation by supplying iron for DNA synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901551-4

Uptake and intracellular handling of iron from transferrin and iron chelates by mitogen stimulated mouse lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901551-4

Pyridoxal isonicotinoyl hydrazone analogs induce apoptosis in hematopoietic cells due to their iron-chelating properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901551-4

In vitro antioxidant properties of the iron chelator pyridoxal isonicotinoyl hydrazone and some of its analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901551-4

The iron chelator pyridoxal isonicotinoyl hydrazone inhibits mitochondrial lipid peroxidation induced by Fe(II)-citrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901551-4

Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901551-4

Mobilization of iron from neoplastic cells by some iron chelators is an energy-dependent process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901551-4

10.1016/S0006-2952(02)01551-4

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference